CIK 0001706431
- Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812730369
- Phone
- +1 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- 4 Open-market sale 10% owner sold 183,547 shares at an average $25.55 ($4,690,136)
- 4 Open-market sale 10% owner sold 136 shares at $25.10 ($3,414)
- 4 Open-market sale 10% owner sold 198,006 shares at an average $25.53 ($5,055,851)
- 4 Open-market sale 10% owner sold 3,075 shares at $25.30 ($77,812)
- 4 Open-market sale 10% owner sold 66,999 shares at an average $25.42 ($1,702,946)
- 4 Open-market sale 10% owner sold 311,983 shares at an average $25.76 ($8,037,394)
- 4 Open-market sale 10% owner sold 83,067 shares at an average $25.12 ($2,086,630)
- 4 Open-market sale 10% owner sold 20,089 shares at an average $25.08 ($503,893)
- 4 Grant or award Chief Executive Officer acquired 576,452 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Technology Officer sold 2,627 shares at $22.77 ($59,817)
- 4 Grant or award Chief Financial Officer acquired 66,500 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 17,935 shares at $22.59 ($405,062)
- 4 Open-market sale EVP & Chief Operating Officer sold 1,482 shares at $22.82 ($33,819)
- 4 Open-market buy Director bought 2,500 shares at $22.73 ($56,816)
- 4 Open-market sale Chief Medical Officer sold 10,320 shares at an average $23.08 ($238,170)
- 4 Open-market sale CFO sold 2,248 shares at $25.97 ($58,387)
- 4 Open-market sale Chief Technology Officer sold 2,302 shares at $25.97 ($59,790)
- 4 Open-market sale President and CEO sold 27,750 shares at an average $24.53 ($680,747)
Page 8 of 25 · 491 filings